Journals / Bezmiâlem Science / 2017 / Cilt: 5 - Sayı: 1

Relationship of Bradykinin B Receptor Gene C-58T Variation with Total-Cholesterol and Glucose in Essential Hypertension

Esansiyel Hipertansiyonda Bradikinin B Reseptör Geni C-58T Polimorfizminin Total-Kolesterol ve Kan Şekeri Üzerine Etkileri

Pages
7–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The C allele was found to have an increasing effect on blood glucose levels (p=0.05) and decreasing effect on total cholesterol levels (p=0.008) in hypertensive patients, whereas it was found to have an increasing effect on waist circumference (p=0.041) in control subjects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Hypertension, which affects 25% of the world's population, is a complex disease, with 30% genes affecting its pathogenesis.
📊
Key Findings & Data:In this study, we aimed to examine the frequency of the bradykinin B2 receptor gene C-58T genotypes in patients with essential hypertension and non-hypertensive controls.
💡
Conclusion & Impact:The C allele was found to have an increasing effect on blood glucose levels (p=0.05) and decreasing effect on total cholesterol levels (p=0.008) in hypertensive patients, whereas it was found to have an increasing effect on waist circumference (p=0.041) in control subjects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Hypertension, which affects 25% of the world's population, is a complex disease, with 30% genes affecting its pathogenesis. In this study, we aimed to examine the frequency of the bradykinin B2 receptor gene C-58T genotypes in patients with essential hypertension and non-hypertensive controls. In addition, we evaluated the effects of C-58T genotypes on demographic characteristics, phenotypes related to obesity, and hypertension. Methods: Genotyping was performed in 63 hypertensive patients and 56 non-hypertensive subjects by PCR-RFLP. Results: The frequency of bradykinin B2 receptor gene C-58T genotypes in hypertensive patients and control subjects was 25.4% and 28.6% for homozygous wild-type (T/T), 49.2% and 58.9% for heterozygous (T/C), and 25.4% and 12.5% for homozygous polymorphic (C/C) genotypes, respectively. Genotype frequencies did not differ significantly among study groups. The C allele was found to have an increasing effect on blood glucose levels (p=0.05) and decreasing effect on total cholesterol levels (p=0.008) in hypertensive patients, whereas it was found to have an increasing effect on waist circumference (p=0.041) in control subjects. Hypertensive patients with C allele were found to use sulfonylurea drugs (p=0.021) at a higher frequency than those with T allele. Further, hypertensive patients with T allele were found to use diuretic drugs (p=0.007) at a higher frequency than those with C allele. Conclusions: The C-58T polymorphism is found to have a positive association with total cholesterol levels, blood glucose levels, and waist circumference but no association with systolic/diastolic blood pressure.

Özet

Amaç: Hipetansiyon, dünya nüfusunun %25'inde etkili olan ve patogenezinde %30 oranında genlerin rol aldığı bir hastalıktır. Bu çalışmada amacımız, Bradikinin B2R geni C-58T genotiplerinin hipertansiyonlu ve hipertansiyonlu olmayan bireylerdeki sıklıklarının tespit edilmesi, C-58T genotiplerinin antropometrik, şişmanlık ve hipertansiyon ilişkili göstergeler üzerine etkisini belirlemektir. Yöntemler: Bradikinin B reseptör geni C-58T genotipleri 63 hipertansiyonlu ve 56 hipertansiyonlu olmayan bireylerde PZRRFLP yöntemi ile belirlenmiştir. Bulgular: Bradikinin B2 reseptör geni C-58T genotip sıklıkları hipertansiyonlu ve hipertansiyonlu olmayan bireylerde sırasıyla homozigot yabanıl tip (T/T) %25,4, %28,6; heterozigot (T/C) %49,2, %58.9 ve homozigot polimorfik tip (C/C) %25,4, %12,5 dir. Çalışma gruplarının genotip sıklıkları arasında istatistiksel anlamlı bir farklılık görülmemiştir. Hipertansiyonlu çalışma grubunda C/C genotipinin açlık kan şekerini (p=0,05) yükseltici, total kolesterolü (p=0,008) düşürücü etkisi tespit edilmiştir. Hipertansiyonlu olmayan çalışma grubunda ise C/C genotipinin bel çevre ölçümünü arttırıcı etkisi saptanmıştır (p=0,041). Hipertansiyonlu çalışma grubunda C/C genotipine sahip bireylerde sulfanülüre (p=0,021) kullanımın sıklığının fazla olduğu ve T/T genotipine sahip bireylerde ise diüretik (p=0,007) kullanım sıklığının fazla olduğu belirlenmiştir. Hipertansiyonu olmayan grupta C/C genotipine sahip bireylerde asetilsalisilik asit (p=0,003) kullanım sıklığının diğer genotiplere kıyasla daha yüksek olduğu tespit edilmiştir. Sonuç: Bradikinin B2 reseptör geni C-58T polimorfizminin açlık kan şekeri, total kolesterol ve bel çevre ölçümleri üzerine etkili olduğu, ancak sistolik ve diastolik kan basıncı üzerine etkili olmadığı görülmüştür.

🔖

Cite This Article

DUMAN, B. S., GÜNDÜZ, M. K., ZENGİN, S. Ü., ÇAĞATAY, P., BOZKUŞ, H. M., BAKIR, N., TAŞKIN, M. (2017). Relationship of Bradykinin B Receptor Gene C-58T Variation with Total-Cholesterol and Glucose in Essential Hypertension. Bezmiâlem Science, Cilt: 5 - Sayı: 1, 7–15. https://ajindex.com/articles/157535

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Niu W, Qi Y, Gao P, Zhu D. A meta-analysis of the bradykinin B2 receptor gene --58C/T polymorphism with hypertension. Clin Chim Acta 2010
  2. [CrossRef] 2. Pesquero JB, Lindsey CJ, Zeh K, Paiva AC, Ganten D, Bader M. Molecular structure and expression of rat bradykinin B2 receptor gene. Evidence for alternative splicing. J Biol Chem 1994
  3. 26920-5. 3. Sharma JN. Hypertension and the bradykinin system. Curr Hypertens Rep 2009
  4. [CrossRef] 4. Regoli D, Rhaleb NE, Drapeau G, Dion S. Kinin receptor subtypes. J Cardiovasc Pharmacol 1990
  5. [CrossRef] 5. Burch RM, Kyle DJ. Recent development in the understanding of bradykinin receptors. Life Sci 1992
  6. [CrossRef] 6. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980
  7. Mattson DL, Cowley AW. Kinin actions on renal papillary blood flow and sodium excretion. Hypertension 1993
  8. [CrossRef] 8. Katori M, Majima M. Role of the renal kallikrein-kinin system in the development of hypertension. Immunopharmacology 1997
  9. [CrossRef] 9. Beard KM, Lu H, Ho K, Fantus IG. Bradykinin augments insulinstimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase. Diabetes 2006
  10. [CrossRef] 10. Duka I, Shenouda S, Johns C, Kintsurashvili E, Gavras I, Gavras H. Role of the B(2) receptor of bradykinin in insulin sensitivity. Hypertension 2001
  11. [CrossRef] 11. Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995
  12. [CrossRef] 12. Henriksen EJ, Jacob S, Augustin HJ, Dietze GJ. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes 1996
  13. [CrossRef] 13. Henriksen EJ, Jacob S, Fogt DL, Dietze GJ. Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance. Am J Physiol 1998
  14. Henriksen EJ, Jacob S, Kinnick TR, Youngblood EB, Schmit MB, Dietze GJ. ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide. Am J Physiol 1999
  15. Miyata T, Taguchi T, Uehara M, Isami S, Kishikawa H, Kaneko K, et al. Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle